| Glioma cells showing IDH1 mutation cannot be propagated in standard cell culture conditions S Piaskowski, M Bienkowski, E Stoczynska-Fidelus, R Stawski, M Sieruta, ... British journal of cancer 104 (6), 968-970, 2011 | 109 | 2011 |
| Human fibroblast-derived cell lines have characteristics of embryonic stem cells and cells of neuro-ectodermal origin P Rieske, B Krynska, SA Azizi Differentiation 73 (9-10), 474-483, 2005 | 91 | 2005 |
| Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system AM Drozd, MP Walczak, S Piaskowski, E Stoczynska-Fidelus, P Rieske, ... Stem cell research & therapy 6, 1-17, 2015 | 78 | 2015 |
| A population of human brain parenchymal cells express markers of glial, neuronal and early neural cells and differentiate into cells of neuronal and glial lineages P Rieske, SA Azizi, B Augelli, J Gaughan, B Krynska European Journal of Neuroscience 25 (1), 31-37, 2007 | 76 | 2007 |
| Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias. I Wojcik, M Szybka, E Golanska, P Rieske, JZ Blonski, T Robak, ... Neoplasma 52 (4), 318-324, 2005 | 75 | 2005 |
| EGFRvIII: An Oncogene with Ambiguous Role A Rutkowska, E Stoczyńska-Fidelus, K Janik, A Włodarczyk, P Rieske Journal of Oncology 2019 (1), 1092587, 2019 | 71 | 2019 |
| AKT induces transcriptional activity of PU. 1 through phosphorylation-mediated modifications within its transactivation domain P Rieske, JMR Pongubala Journal of Biological Chemistry 276 (11), 8460-8468, 2001 | 66 | 2001 |
| Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors P Rieske, E Golanska, M Zakrzewska, S Piaskowski, ... BMC cancer 9, 1-15, 2009 | 61 | 2009 |
| GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis S Piaskowski, P Rieske, M Szybka, K Wozniak, A Bednarek, E Płuciennik, ... Cancer genetics and cytogenetics 162 (1), 63-67, 2005 | 56 | 2005 |
| Directed differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6. 1 factors in IPC progenitors MP Walczak, AM Drozd, E Stoczynska-Fidelus, P Rieske, DP Grzela Journal of Translational Medicine 14, 1-16, 2016 | 45 | 2016 |
| High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations E Jesien-Lewandowicz, D Jesionek-Kupnicka, I Zawlik, M Szybka, ... Cancer genetics and cytogenetics 188 (2), 77-82, 2009 | 44 | 2009 |
| Efficient and simple approach to in vitro culture of primary epithelial cancer cells K Janik, M Popeda, J Peciak, K Rosiak, M Smolarz, C Treda, P Rieske, ... Bioscience reports 36 (6), e00423, 2016 | 42 | 2016 |
| Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients M Bieńkowski, S Piaskowski, E Stoczyńska-Fidelus, M Szybka, ... PloS one 8 (6), e65444, 2013 | 42 | 2013 |
| EGFR activation leads to cell death independent of PI3K/AKT/mTOR in an AD293 cell line C Treda, M Popeda, M Ksiazkiewicz, DP Grzela, MP Walczak, ... PLoS One 11 (5), e0155230, 2016 | 39 | 2016 |
| Assessment of OPG/RANK/RANKL Gene Expression Levels in Peripheral Blood Mononuclear Cells (PBMC) After Treatment With Strontium Ranelate and … M Stuss, P Rieske, A Cegłowska, W Stêpień-Kłos, PP Liberski, ... The Journal of Clinical Endocrinology & Metabolism 98 (5), E1007-E1011, 2013 | 39 | 2013 |
| Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies M Witusik-Perkowska, P Rieske, K Hułas-Bigoszewska, M Zakrzewska, ... Journal of neuro-oncology 102, 395-407, 2011 | 39 | 2011 |
| Molecular heterogeneity of meningioma with INI1 mutation P Rieske, M Zakrzewska, S Piaskowski, D Jaskólski, B Sikorska, ... Molecular Pathology 56 (5), 299, 2003 | 38 | 2003 |
| BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region K Wozniak, S Piaskowski, SM Gresner, E Golanska, E Bieniek, ... Cancer genetics and cytogenetics 183 (1), 14-20, 2008 | 37 | 2008 |
| Cell line with endogenous EGFRvIII expression is a suitable model for research and drug development purposes WJ Stec, K Rosiak, P Siejka, J Peciak, M Popeda, M Banaszczyk, ... Oncotarget 7 (22), 31907, 2016 | 31 | 2016 |
| CYP46: a risk factor for Alzheimer's disease or a coincidence? E Golanska, K Hulas-Bigoszewska, I Wojcik, P Rieske, M Styczynska, ... Neuroscience letters 383 (1-2), 105-108, 2005 | 31 | 2005 |
